
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3

Net Margin
Ouro Fino Saude Animal Participacoes SA
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
BR |
![]() |
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
1.2B BRL |
79%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
763B USD |
24%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.9B USD |
16%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK |
35%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
233.1B CHF |
20%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
176.2B GBP |
13%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.3B CHF |
23%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
220.6B USD |
27%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD |
-126%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
139B USD |
13%
|
Ouro Fino Saude Animal Participacoes SA
Glance View
Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Ouro Fino Saude Animal Participacoes SA's most recent financial statements, the company has Net Margin of 79.5%.